vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and VALMONT INDUSTRIES INC (VMI). Click either name above to swap in a different company.
VALMONT INDUSTRIES INC is the larger business by last-quarter revenue ($1.0B vs $346.4M, roughly 3.0× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 28.1% vs 16.2%, a 11.9% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (4.8% vs 0.1%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $70.4M). Over the past eight quarters, VALMONT INDUSTRIES INC's revenue compounded faster (3.0% CAGR vs 1.5%).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Valmont Industries, Inc. is a large, publicly held American manufacturer of Valley center pivot and linear irrigation equipment, windmill support structures, lighting and traffic poles and steel utility poles.
HAE vs VMI — Head-to-Head
Income Statement — Q4 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $346.4M | $1.0B |
| Net Profit | $97.3M | $168.0M |
| Gross Margin | 57.2% | 29.8% |
| Operating Margin | 36.1% | 11.2% |
| Net Margin | 28.1% | 16.2% |
| Revenue YoY | 4.8% | 0.1% |
| Net Profit YoY | — | 116.3% |
| EPS (diluted) | — | $9.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $346.4M | — | ||
| Q4 25 | $339.0M | $1.0B | ||
| Q3 25 | $327.3M | $1.0B | ||
| Q2 25 | $321.4M | $1.1B | ||
| Q1 25 | $330.6M | $969.3M | ||
| Q4 24 | $348.5M | $1.0B | ||
| Q3 24 | $345.5M | $1.0B | ||
| Q2 24 | $336.2M | $1.0B |
| Q1 26 | $97.3M | — | ||
| Q4 25 | $44.7M | $168.0M | ||
| Q3 25 | $38.7M | $99.0M | ||
| Q2 25 | $34.0M | $-4.0M | ||
| Q1 25 | $58.0M | $87.3M | ||
| Q4 24 | $37.5M | $77.7M | ||
| Q3 24 | $33.8M | $83.1M | ||
| Q2 24 | $38.4M | $99.7M |
| Q1 26 | 57.2% | — | ||
| Q4 25 | 59.7% | 29.8% | ||
| Q3 25 | 59.5% | 30.4% | ||
| Q2 25 | 59.8% | 30.6% | ||
| Q1 25 | 58.4% | 30.0% | ||
| Q4 24 | 55.5% | 30.2% | ||
| Q3 24 | 54.2% | 29.6% | ||
| Q2 24 | 52.0% | 30.8% |
| Q1 26 | 36.1% | — | ||
| Q4 25 | 19.9% | 11.2% | ||
| Q3 25 | 17.9% | 13.5% | ||
| Q2 25 | 16.8% | 2.8% | ||
| Q1 25 | 21.6% | 13.2% | ||
| Q4 24 | 16.9% | 11.6% | ||
| Q3 24 | 15.0% | 12.3% | ||
| Q2 24 | 11.8% | 14.2% |
| Q1 26 | 28.1% | — | ||
| Q4 25 | 13.2% | 16.2% | ||
| Q3 25 | 11.8% | 9.5% | ||
| Q2 25 | 10.6% | -0.4% | ||
| Q1 25 | 17.5% | 9.0% | ||
| Q4 24 | 10.8% | 7.5% | ||
| Q3 24 | 9.8% | 8.1% | ||
| Q2 24 | 11.4% | 9.6% |
| Q1 26 | — | — | ||
| Q4 25 | $0.95 | $9.02 | ||
| Q3 25 | $0.81 | $4.98 | ||
| Q2 25 | $0.70 | $-1.53 | ||
| Q1 25 | $1.17 | $4.32 | ||
| Q4 24 | $0.74 | $3.85 | ||
| Q3 24 | $0.66 | $4.11 | ||
| Q2 24 | $0.74 | $4.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.4M | $187.1M |
| Total DebtLower is stronger | $1.2B | $795.7M |
| Stockholders' EquityBook value | $796.3M | $1.6B |
| Total Assets | $2.4B | $3.4B |
| Debt / EquityLower = less leverage | 1.53× | 0.49× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.4M | — | ||
| Q4 25 | $363.4M | $187.1M | ||
| Q3 25 | $296.4M | $226.1M | ||
| Q2 25 | $292.9M | $208.5M | ||
| Q1 25 | $306.8M | $184.4M | ||
| Q4 24 | $320.8M | $164.3M | ||
| Q3 24 | $299.3M | $200.5M | ||
| Q2 24 | $344.4M | $163.1M |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $795.7M | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | $730.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $796.3M | — | ||
| Q4 25 | $911.5M | $1.6B | ||
| Q3 25 | $849.2M | $1.6B | ||
| Q2 25 | $882.3M | $1.5B | ||
| Q1 25 | $820.8M | $1.6B | ||
| Q4 24 | $906.9M | $1.5B | ||
| Q3 24 | $878.9M | $1.5B | ||
| Q2 24 | $905.4M | $1.5B |
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.5B | $3.4B | ||
| Q3 25 | $2.4B | $3.4B | ||
| Q2 25 | $2.5B | $3.3B | ||
| Q1 25 | $2.5B | $3.4B | ||
| Q4 24 | $2.5B | $3.3B | ||
| Q3 24 | $2.5B | $3.5B | ||
| Q2 24 | $2.5B | $3.5B |
| Q1 26 | 1.53× | — | ||
| Q4 25 | 1.34× | 0.49× | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 1.39× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $293.2M | $111.2M |
| Free Cash FlowOCF − Capex | $209.9M | $70.4M |
| FCF MarginFCF / Revenue | 60.6% | 6.8% |
| Capex IntensityCapex / Revenue | 9.5% | 3.9% |
| Cash ConversionOCF / Net Profit | 3.01× | 0.66× |
| TTM Free Cash FlowTrailing 4 quarters | $417.1M | $311.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $293.2M | — | ||
| Q4 25 | $93.6M | $111.2M | ||
| Q3 25 | $111.3M | $112.5M | ||
| Q2 25 | $17.4M | $167.6M | ||
| Q1 25 | $116.6M | $65.1M | ||
| Q4 24 | $43.8M | $193.4M | ||
| Q3 24 | $48.8M | $225.1M | ||
| Q2 24 | $-27.4M | $130.8M |
| Q1 26 | $209.9M | — | ||
| Q4 25 | $87.2M | $70.4M | ||
| Q3 25 | $106.3M | $70.6M | ||
| Q2 25 | $13.6M | $135.6M | ||
| Q1 25 | $100.9M | $34.8M | ||
| Q4 24 | $35.2M | $167.8M | ||
| Q3 24 | $39.4M | $204.6M | ||
| Q2 24 | $-33.1M | $112.5M |
| Q1 26 | 60.6% | — | ||
| Q4 25 | 25.7% | 6.8% | ||
| Q3 25 | 32.5% | 6.7% | ||
| Q2 25 | 4.2% | 12.9% | ||
| Q1 25 | 30.5% | 3.6% | ||
| Q4 24 | 10.1% | 16.2% | ||
| Q3 24 | 11.4% | 20.1% | ||
| Q2 24 | -9.8% | 10.8% |
| Q1 26 | 9.5% | — | ||
| Q4 25 | 1.9% | 3.9% | ||
| Q3 25 | 1.5% | 4.0% | ||
| Q2 25 | 1.2% | 3.0% | ||
| Q1 25 | 4.7% | 3.1% | ||
| Q4 24 | 2.5% | 2.5% | ||
| Q3 24 | 2.7% | 2.0% | ||
| Q2 24 | 1.7% | 1.8% |
| Q1 26 | 3.01× | — | ||
| Q4 25 | 2.09× | 0.66× | ||
| Q3 25 | 2.88× | 1.14× | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 2.01× | 0.75× | ||
| Q4 24 | 1.17× | 2.49× | ||
| Q3 24 | 1.44× | 2.71× | ||
| Q2 24 | -0.71× | 1.31× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
VMI
| Utility Product Line | $424.5M | 41% |
| Lighting And Transportation | $204.6M | 20% |
| Irrigation Equipment And Parts Excluding Technology | $199.0M | 19% |
| Services | $113.6M | 11% |
| Telecommunications | $73.8M | 7% |
| Technology Products And Services | $23.7M | 2% |
